ATE405258T1 - Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure - Google Patents

Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure

Info

Publication number
ATE405258T1
ATE405258T1 AT04760019T AT04760019T ATE405258T1 AT E405258 T1 ATE405258 T1 AT E405258T1 AT 04760019 T AT04760019 T AT 04760019T AT 04760019 T AT04760019 T AT 04760019T AT E405258 T1 ATE405258 T1 AT E405258T1
Authority
AT
Austria
Prior art keywords
fatty acid
alkaneous
tissue
acid
blood flow
Prior art date
Application number
AT04760019T
Other languages
English (en)
Inventor
David Elmaleh
Alan Fischman
Timothy Shoup
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE405258T1 publication Critical patent/ATE405258T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT04760019T 2003-04-17 2004-04-19 Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure ATE405258T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46357403P 2003-04-17 2003-04-17

Publications (1)

Publication Number Publication Date
ATE405258T1 true ATE405258T1 (de) 2008-09-15

Family

ID=33310796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04760019T ATE405258T1 (de) 2003-04-17 2004-04-19 Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure

Country Status (10)

Country Link
US (9) US7494642B2 (de)
EP (1) EP1622602B1 (de)
JP (1) JP4633052B2 (de)
AT (1) ATE405258T1 (de)
AU (1) AU2004232297B2 (de)
CA (1) CA2522737C (de)
DE (1) DE602004015970D1 (de)
HK (1) HK1083414A1 (de)
MX (1) MXPA05011189A (de)
WO (1) WO2004093650A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238860C (en) * 1995-12-01 2009-01-13 David R. Elmaleh Stereoisomers of fatty acid analogs for diagnostic imaging
US8565860B2 (en) 2000-08-21 2013-10-22 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system
US8489176B1 (en) 2000-08-21 2013-07-16 Spectrum Dynamics Llc Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US8909325B2 (en) 2000-08-21 2014-12-09 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
WO2004093650A2 (en) * 2003-04-17 2004-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
US8586932B2 (en) 2004-11-09 2013-11-19 Spectrum Dynamics Llc System and method for radioactive emission measurement
US7176466B2 (en) 2004-01-13 2007-02-13 Spectrum Dynamics Llc Multi-dimensional image reconstruction
US9040016B2 (en) 2004-01-13 2015-05-26 Biosensors International Group, Ltd. Diagnostic kit and methods for radioimaging myocardial perfusion
US9470801B2 (en) 2004-01-13 2016-10-18 Spectrum Dynamics Llc Gating with anatomically varying durations
US8571881B2 (en) 2004-11-09 2013-10-29 Spectrum Dynamics, Llc Radiopharmaceutical dispensing, administration, and imaging
WO2007010534A2 (en) 2005-07-19 2007-01-25 Spectrum Dynamics Llc Imaging protocols
US7968851B2 (en) 2004-01-13 2011-06-28 Spectrum Dynamics Llc Dynamic spect camera
EP1778957A4 (de) 2004-06-01 2015-12-23 Biosensors Int Group Ltd Optimierung der messung radioaktiver strahlung an besonderen körperstrukturen
US8615405B2 (en) 2004-11-09 2013-12-24 Biosensors International Group, Ltd. Imaging system customization using data from radiopharmaceutical-associated data carrier
US8423125B2 (en) 2004-11-09 2013-04-16 Spectrum Dynamics Llc Radioimaging
EP1827505A4 (de) 2004-11-09 2017-07-12 Biosensors International Group, Ltd. Radiodarstellung
US9316743B2 (en) 2004-11-09 2016-04-19 Biosensors International Group, Ltd. System and method for radioactive emission measurement
US9943274B2 (en) 2004-11-09 2018-04-17 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
WO2008059489A2 (en) 2006-11-13 2008-05-22 Spectrum Dynamics Llc Radioimaging applications of and novel formulations of teboroxime
US8837793B2 (en) 2005-07-19 2014-09-16 Biosensors International Group, Ltd. Reconstruction stabilizer and active vision
GB0525949D0 (en) * 2005-12-21 2006-02-01 Hammersmith Imanet Ltd Pet radiotracers
US20090177098A1 (en) * 2006-01-16 2009-07-09 Kousuke Yakubo Examination System and Examination Method
US8894974B2 (en) 2006-05-11 2014-11-25 Spectrum Dynamics Llc Radiopharmaceuticals for diagnosis and therapy
WO2008075362A2 (en) 2006-12-20 2008-06-26 Spectrum Dynamics Llc A method, a system, and an apparatus for using and processing multidimensional data
US8521253B2 (en) 2007-10-29 2013-08-27 Spectrum Dynamics Llc Prostate imaging
BRPI1014538A2 (pt) * 2009-05-04 2016-04-05 Univ Washington radiotraçadores pet para imagear metabolismo e armazenamento de ácido graxo
WO2010144876A1 (en) * 2009-06-12 2010-12-16 University Of Louisville Research Foundation, Inc Methods to detect cancer in animals
US8338788B2 (en) 2009-07-29 2012-12-25 Spectrum Dynamics Llc Method and system of optimized volumetric imaging
US20110110570A1 (en) * 2009-11-10 2011-05-12 Avi Bar-Shalev Apparatus and methods for generating a planar image
DE102010010666A1 (de) * 2010-03-01 2011-09-01 Sven Reske Diagnose und Therapie von Krebserkrankungen mittels Fettsäuren
RU2016112494A (ru) * 2013-09-06 2017-10-11 Конинклейке Филипс Н.В. Устройство обработки для обработки данных сердечной деятельности
DK3538161T3 (da) * 2016-11-08 2022-09-05 Univ California Fremgangsmåder til flerdosissyntese af [F-18]FDDNP til kliniske indstillinger
CN108727229B (zh) * 2017-04-17 2021-07-02 北京先通国际医药科技股份有限公司 一种修饰脂肪酸型pet试剂前体的新工艺路线
EP3825302A4 (de) * 2018-07-20 2022-05-04 Astellas Pharma Inc. Mit positron-emittierendem radionuklid markiertes fettsäurederivat
CN116351339A (zh) * 2022-06-07 2023-06-30 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114732918B (zh) * 2022-06-10 2022-09-13 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114736112A (zh) * 2022-06-14 2022-07-12 北京先通国际医药科技股份有限公司 一种心肌代谢pet显像剂的制备方法及用途
CN114773179B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 一种化合物ⅰ液体组合物的制备方法、及其在心肌代谢pet显像上的用途
CN114796534B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 包含化合物ⅰ的液体组合物、制备方法及用途
CN115850224A (zh) * 2022-07-22 2023-03-28 北京先通国际医药科技股份有限公司 一种修饰长链脂肪酸型pet试剂前体的合成方法及其用途
CN115181013B (zh) * 2022-07-22 2023-08-08 北京先通国际医药科技股份有限公司 修饰脂肪酸型pet试剂前体关键中间体的制备方法及其用途
CN115141087B (zh) * 2022-09-06 2023-03-24 北京先通国际医药科技股份有限公司 Pet前体关键中间体的异构体的合成方法及其用途
CN115970012A (zh) * 2023-03-16 2023-04-18 北京先通国际医药科技股份有限公司 正电子心肌脂肪酸代谢显像剂与正电子18f-fdg心肌葡萄糖显像剂用于pet联合显像的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119640A (en) * 1975-07-10 1978-10-10 Union Carbide Corporation Polymerizable epoxide-modified compositions
DE2828623C2 (de) * 1978-06-29 1983-11-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung
US4202902A (en) 1979-03-05 1980-05-13 Shell Oil Company Lipogenesis control by cyclopropane-carboxylic acids, esters and amides
US4524059A (en) * 1983-01-28 1985-06-18 The General Hospital Corporation Fatty acid analogs
US4933365A (en) * 1989-01-25 1990-06-12 American Home Products Corporation Phospholipase A2 inhibitors
DE4012405C1 (en) * 1990-04-19 1991-08-14 Forschungszentrum Juelich Gmbh, 5170 Juelich, De Radioisotope labelled oxiranyl carboxylic acid derivs. prodn. - by nucleophilic replacement of corresp. bromo or iodo substits. with radioactive alkali halide(s) in polar medium
CA2238860C (en) 1995-12-01 2009-01-13 David R. Elmaleh Stereoisomers of fatty acid analogs for diagnostic imaging
IT1295658B1 (it) * 1997-09-29 1999-05-24 Menarini Ricerche Spa Composizioni farmaceutiche contenenti acido ricinoleico e loro uso per la terapia antifiammatoria ed analgesica
EP1173226B1 (de) 1999-04-14 2006-08-23 Molecular Insight Pharmaceuticals, Inc. Fettsaure analoge zur diagnose von kranzarterie erkrankungen
WO2004092184A1 (de) 2003-04-12 2004-10-28 Forschungszentrum Rossendorf E.V. Technetiummarkierte fettsäuren und deren verwendung für die myokarddiagnostik sowie verfahren zur herstellung der technetiummarkierten fettsäuren
WO2004093650A2 (en) 2003-04-17 2004-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
KR101574279B1 (ko) * 2008-04-04 2015-12-04 어드밴스드 마이크로 디바이시즈, 인코포레이티드 앤티 엘리어싱을 위한 필터링 방법 및 장치

Also Published As

Publication number Publication date
US20080095702A1 (en) 2008-04-24
HK1083414A1 (en) 2006-06-30
EP1622602B1 (de) 2008-08-20
US8871179B2 (en) 2014-10-28
JP2006524250A (ja) 2006-10-26
US7494642B2 (en) 2009-02-24
WO2004093650A3 (en) 2005-04-14
US20080214853A1 (en) 2008-09-04
AU2004232297B2 (en) 2010-11-04
JP4633052B2 (ja) 2011-02-16
EP1622602A4 (de) 2006-06-21
US7790142B2 (en) 2010-09-07
US20080213173A1 (en) 2008-09-04
US20080206135A1 (en) 2008-08-28
US20130052129A1 (en) 2013-02-28
US20080213178A1 (en) 2008-09-04
DE602004015970D1 (de) 2008-10-02
WO2004093650A2 (en) 2004-11-04
AU2004232297A1 (en) 2004-11-04
US8268291B2 (en) 2012-09-18
US20080214851A1 (en) 2008-09-04
EP1622602A2 (de) 2006-02-08
CA2522737A1 (en) 2004-11-04
CA2522737C (en) 2017-06-06
US20090156848A1 (en) 2009-06-18
US8309053B2 (en) 2012-11-13
US20040253177A1 (en) 2004-12-16
MXPA05011189A (es) 2006-05-25

Similar Documents

Publication Publication Date Title
ATE405258T1 (de) Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure
DE60324180D1 (de) Behandlung der huntington's krankheit mit epa
EA200401365A1 (ru) Способы лечения илеуса
DK1660528T3 (da) Mutein af tåre-lipocalin
DE602005012233D1 (de) Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
EA200800908A1 (ru) Получение прегабалина и родственных соединений
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
DE602005020269D1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DK1812076T3 (da) Blodpladeafledte vækstfaktorsammensætninger og fremgangsmåder til anvendelse heraf
BRPI0510623A (pt) compostos de derivados de prolina e morfolina
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
EP1539228A4 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
AR002241A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
ATE478062T1 (de) Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
EA200201214A1 (ru) Замещенные тиоацетамиды
HRP20050743A2 (en) 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivates and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
BRPI0410979A (pt) composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
EA200200232A1 (ru) Интерлейкин-5 ингибирующие производные 6-азаурацила
ATE540964T1 (de) Neue mehrfach ungesättigte verbindungen, verfahren zu deren herstellung zusammensetzungen, die diese enthalten
UY30014A1 (es) Subgrupo de compuestos basados en oxabispidina comprendiendo un grupo alquilo amidasustituido, proceso de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones
BRPI0415434A (pt) compostos e métodos para tratar e prevenir arritmias cardìacas induzidas por exercìcios
ECSP056103A (es) Tratamiento de pigmentos de alto rendimiento

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties